AHIP Statement On Proposed Prescription Drug Rebate Rule

posted by AHIP

on July 11, 2019

WASHINGTON, D.C. –  Matt Eyles, president and CEO of America’s Health Insurance Plans (AHIP), issued this statement following the administration’s decision to withdraw the proposed Part D safe harbor rebate rule, which would have eliminated drug pricing rebates from Medicare and Medicaid programs.

“Prescription drug prices are out-of-control, and we must work on solutions to reduce the price and cost of prescription drugs for all Americans, including seniors and taxpayers.  As we all know, drug prices and price increases are set and controlled solely by drug makers. They alone could decide to reduce prices – and can do so today.

“AHIP joins the Administration and the Congress in their goal of lowering costs and making drugs more affordable and accessible for all Americans. We will continue to work with them, and all stakeholders, to find bold solutions that promote greater competition, open and honest drug pricing, and paying for value.  By focusing on these solutions, we can lower what patients and consumers pay at the pharmacy counter, in premiums, and in taxes – making health care more affordable and accessible for everyone.”

" "